{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6"],"submitter":["Bekos C"],"pubmed_abstract":["Conflicting data exist on the relevance of marathon (M) and half marathon (HM) running for health. The number of non-professional athletes finishing M and HM events is steadily growing. In order to investigate molecular changes occurring in amateur athletes, we enrolled 70 non-professional runners finishing a single M (34) or HM (36) event at baseline, the finish line and during recovery, and 30 controls. The measurement of the Receptor for Advanced Glycation Endproducts, Interleukin 1 receptor antagonist, ST2 and cytokeratin 18 was combined with molecules measured during clinical routine. Results were analyzed in the light of blood cell analysis, lactate measurements, correction for changes in plasma volume and body composition assessments. There were intrinsic differences in body mass in"],"journal":["Scientific reports"],"pagination":["32315"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5032027"],"repository":["biostudies-literature"],"pubmed_title":["Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal function."],"pmcid":["PMC5032027"],"pubmed_authors":["Kessler M","Bekos C","Nickl S","Unger L","Koller M","Mitterbauer A","Roth G","Hacker P","Zimmermann M","Moser B","Fritz R","Didcock J","Altmann P","Ankersmit HJ","Klepetko W","Gabler C","Haider T","Janik S"],"additional_accession":[]},"is_claimable":false,"name":"Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal function.","description":"Conflicting data exist on the relevance of marathon (M) and half marathon (HM) running for health. The number of non-professional athletes finishing M and HM events is steadily growing. In order to investigate molecular changes occurring in amateur athletes, we enrolled 70 non-professional runners finishing a single M (34) or HM (36) event at baseline, the finish line and during recovery, and 30 controls. The measurement of the Receptor for Advanced Glycation Endproducts, Interleukin 1 receptor antagonist, ST2 and cytokeratin 18 was combined with molecules measured during clinical routine. Results were analyzed in the light of blood cell analysis, lactate measurements, correction for changes in plasma volume and body composition assessments. There were intrinsic differences in body mass in","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Sep","modification":"2025-06-01T00:28:07.737Z","creation":"2025-06-01T00:28:07.737Z"},"accession":"S-EPMC5032027","cross_references":{"pubmed":["27653273"],"doi":["10.1038/srep32315"]}}